EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Intracellular PD-L1: Functions, Regulation, and Therapeutic Implications

Youliang Zhao, Yaqian Qu, Changfu Hao, Wu Yao

International Journal of Biological Sciences · 13.07.2026 · 22 (12) · 6608-6630

DOI: 10.7150/ijbs.133650 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, erschienen am 13.07.2026. Verfasst von Youliang Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Occupational Health and Occupational Disease, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: B7-H1 Antigen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Programmed death-ligand 1 (PD-L1) has long been characterized as a membrane-bound immune checkpoint ligand that suppresses antitumor immunity through engagement with PD-1 on T cells. This canonical understanding has underpinned the development of therapeutic antibodies that have revolutionized cancer treatment. However, PD-1/PD-L1 immunotherapy still has limitations such as poor response rates and post-treatment resistance. Notably, emerging evidence reveals that the roles of PD-L1 extend beyond its membrane-bound form, with substantial pools residing in the cytoplasm, nucleus, organelles, and extracellular vesicles. These intracellular PD-L1 populations perform distinct, often immune-independent functions including transcriptional regulation, mRNA stability control, DNA damage response modulation, and metabolic reprogramming. This review examines the subcellular localization of PD-L1, the mechanisms governing its trafficking and compartmentalization, its compartment-specific biological functions, and the corresponding clinical significance. Understanding the full spectrum of PD-L1 biology is essential for developing more effective immunotherapeutic approaches and promoting individualized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenHumansAnimalsNeoplasmsImmunotherapy

Stichwörter der Autor:innen

PD-L1cancer immunotherapyimmune checkpointposttranslational regulationsubcellular compartmentalization

Substanzen

B7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Occupational Health and Occupational Disease, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
  • School of medicine, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.

Zitieren

APA

Zhao, Y., Qu, Y., Hao, C., & Yao, W. (2026). Intracellular PD-L1: Functions, Regulation, and Therapeutic Implications. International Journal of Biological Sciences, 22(12), 6608-6630. https://doi.org/10.7150/ijbs.133650

Vancouver

Zhao Y, Qu Y, Hao C, Yao W. Intracellular PD-L1: Functions, Regulation, and Therapeutic Implications. International Journal of Biological Sciences. 2026;22(12):6608-6630. doi:10.7150/ijbs.133650

BibTeX
@article{Zhao2026,
  author = {Zhao, Youliang and Qu, Yaqian and Hao, Changfu and Yao, Wu},
  title = {Intracellular PD-L1: Functions, Regulation, and Therapeutic Implications},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {12},
  pages = {6608--6630},
  doi = {10.7150/ijbs.133650}
}
Kostenlos starten →